Европска Унија - Шведски - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - fetma - antiobesity preparat, exkl. kost produkter - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

Шведска - Шведски - Läkemedelsverket (Medical Products Agency)

sintetica gmbh - efedrinhydroklorid - injektionsvätska, lösning - 10 mg/ml - efedrinhydroklorid 10 mg aktiv substans

Шведска - Шведски - Läkemedelsverket (Medical Products Agency)

sintetica gmbh - efedrinhydroklorid - injektionsvätska, lösning - 50 mg/ml - efedrinhydroklorid 50 mg aktiv substans

Шведска - Шведски - Läkemedelsverket (Medical Products Agency)

clinigen healthcare b.v. - glykopyrroniumbromid - oral lösning - 160 mikrogram/ml - glycerol hjälpämne; glykopyrroniumbromid 200 mikrog aktiv substans; natriumpropylparahydroxibensoat hjälpämne; natriummetylparahydroxibensoat hjälpämne; sorbitol hjälpämne

Шведска - Шведски - Läkemedelsverket (Medical Products Agency)

as kalceks - dexametasonnatriumfosfat - injektions-/infusionsvätska, lösning - 4 mg/ml - dexametasonnatriumfosfat 4,37 mg aktiv substans

Шведска - Шведски - Läkemedelsverket (Medical Products Agency)

ebb medical ab - lisdexamfetamindimesilat - kapsel, hård - 30 mg - propylenglykol hjälpämne; lisdexamfetamindimesilat 30 mg aktiv substans

Европска Унија - Шведски - EMA (European Medicines Agency)

pfizer europe ma eeig  - rimegepant - migrän störningar - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.

Европска Унија - Шведски - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - leukemi, myelogen, kronisk, bcr-abl positiv - antineoplastiska medel - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Шведска - Шведски - Läkemedelsverket (Medical Products Agency)

croma-pharma gmbh - clostridium botulinum typ a neurotoxin - pulver till injektionsvätska, lösning - 50 enheter - clostridium botulinum typ a neurotoxin 50 e aktiv substans

Шведска - Шведски - Läkemedelsverket (Medical Products Agency)

stada arzneimittel ag - lisdexamfetamindimesilat - kapsel, hård - 30 mg - lisdexamfetamindimesilat 30 mg aktiv substans; propylenglykol hjälpämne